Fish on Prozac (and Zoloft): Ten years later

Aquatic Toxicology

Volumn 151, Issue , 2014, Pages 61-67

  Brooks, Bryan W ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

Adverse outcome pathways; Chirality; Comparative pharmacology and toxicology; Contaminants of emerging concern; Hazard assessment; Ionization; Risk assessment; Therapeutic hazard value; Urbanization; Water resources

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

DRUG; ENVIRONMENTAL ASSESSMENT; ENVIRONMENTAL EDUCATION; ENVIRONMENTAL IMPACT; ENVIRONMENTAL MANAGEMENT; FISH; HAZARD ASSESSMENT; POLLUTION EFFECT; POLLUTION EXPOSURE; RISK ASSESSMENT; STREAMWATER; TOXICOLOGY; URBANIZATION; WATER RESOURCE;

BIOACCUMULATION; CHIRALITY; CONTROLLED STUDY; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL PROTECTION; FISH; HAZARD ASSESSMENT; INDICATOR ORGANISM; IONIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; URBAN AREA; WATER CONTAMINATION; WATER CYCLE;

MAMMALIA;

ADVERSE OUTCOME PATHWAYS; CHIRALITY; COMPARATIVE PHARMACOLOGY AND TOXICOLOGY; CONTAMINANTS OF EMERGING CONCERN; HAZARD ASSESSMENT; IONIZATION; RISK ASSESSMENT; THERAPEUTIC HAZARD VALUE; URBANIZATION; WATER RESOURCES;

ANIMALS; AQUATIC ORGANISMS; CONSERVATION OF NATURAL RESOURCES; FISHES; FLUOXETINE; RESEARCH; WATER CYCLE; WATER POLLUTANTS, CHEMICAL;

EID: 84899484575     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2014.01.007     Document Type: Review

References (80)

1. Ankley G.T., Brooks B.W., Huggett D.B., Sumpter J.P. Repeating history: pharmaceuticals in the environment. Environmental Science and Technology 2007, 41:8211-8217.
2. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environmental Toxicology and Chemistry 2010, 29:730-741.
3. Berninger J.P., Brooks B.W. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicology Letters 2010, 193:69-78.
4. Berninger J.P., Du B., Connors K.A., Eytcheson S.A., Kolkmeier M.A., Prosser K.N., Valenti T.W., Chambliss C.K., Brooks B.W. Effects of the antihistamine diphenhydramine to select aquatic organisms. Environmental Toxicology and Chemistry 2011, 30:2065-2072.
5. Bisesi J.H., Bridges W., Klaine S.J. Effects of the antidepressant venlafaxine on fish brain serotonin and predation behavior. Aquatic Toxicology 2014, http://dx.doi.org/10.1016/j.aquatox.2013.12.033.
6. Boxall A.B.A., Rudd M., Brooks B.W., Caldwell D., Choi K., Hickmann S., Innes E., Ostapyk K., Staveley J., Verslycke T., Ankley G.T., Beazley K., Belanger S., Berninger J.P., Carriquiriborde P., Coors A., DeLeo P., Dyer S., Ericson J., Gagne F., Giesy J.P., Gouin T., Hallstrom L., Karlsson M., Larsson D.G.J., Lazorchak J., Mastrococco F., McLaughlin A., McMaster M., Meyerhoff R., Moore R., Parrott J., Snape J., Murray-Smith R., Servos M., Sibley P.K., Straub J.O., Szabo N., Tetrault G., Topp E., Trudeau V.L., van der Kraak G. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environmental Health Perspectives 2012, 120:1221-1229.
7. Brain R.A., Reitsma T.S., Lissemore L.I., Bestari K., Sibley P.K., Solomon K.R. Herbicidal effects of statin pharmaceuticals in Lemna gibba. Environmental Science and Technology 2006, 40:5117-5123.
8. Brain R.A., Ramirez A.J., Fulton B.A., Chambliss C.K., Brooks B.W. Herbicidal effects of sulfamethoxazole in Lemna gibba: using p-aminobenzoic acid as a biomarker of effect. Environmental Science and Technology 2008, 42:8965-8970.
9. Brain R.A., Hanson M., Solomon K.R., Brooks B.W. Aquatic plants exposed to pharmaceuticals: effects and risks. Reviews of Environmental Contamination and Toxicology 2008, 192:67-115.
10. Brausch J.M., Connors K.A., Brooks B.W., Rand G.M. Human pharmaceuticals in the aquatic environment: a critical review of recent toxicological studies and considerations for toxicity testing. Reviews of Environmental Contamination and Toxicology 2012, 218:1-99.
11. Brooks B.W., Turner P.K., Stanley J.K., Weston J., Glidewell E., Foran C.M., Slattery M., La Point T.W., Huggett D.B. Waterborne and sediment toxicity of fluoxetine to selected organisms. Chemosphere 2003, 52:135-142.
12. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicology Letters 2003, 142:169-183.
13. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Russell J.L. Determination of select antidepressants in fish from an effluent-dominated stream. Environmental Toxicology and Chemistry 2005, 24:464-469.
14. Brooks B.W., Riley T.M., Taylor R.D. Water quality of effluent-dominated ecosystems: ecotoxicological, hydrological, and management considerations. Hydrobiologia 2006, 556:365-379.
15. Brooks B.W., Huggett D., Boxall A. Pharmaceuticals and personal care products in the environment: research needs for the next decade. Environmental Toxicology and Chemistry 2009, 28:2469-2472.
16. Brooks B.W., Brain R.A., Huggett D.B., Ankley G.T. Risk assessment considerations for veterinary medicines in aquatic ecosystems. Veterinary Pharmaceuticals in the Environment 2009, 205-223. American Chemical Society, Washington DC. K.L. Henderson, J.R. Coats (Eds.).
17. Brooks B.W., Berninger J.P., Kristofco L.A., Ramirez A.J., Stanley J.K., Valenti T.W. Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment. Progress in Molecular Biology and Translational Science 2012, 112:231-258.
18. Brooks B.W., Berninger J.P., Ramirez A.J., Huggett D.B. Perspectives on human pharmaceuticals in the environment. Human Pharmaceuticals in the Environment: Current and Future Perspectives 2012, 1-16. Springer, New York, NY. B.W. Brooks, D.B. Huggett (Eds.).
19. Brown J.N., Paxeus N., Forlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environmental Toxicology and Pharmacology 2007, 24:267-274.
20. Caldwell, D.J., Mastrocco, F., Margiotta-Casaluci, L., Brooks, B.W. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. Accepted, Chemosphere.
21. Christensen A.M., Faaborg-Andersen S., Ingerslev F., Baun A. Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans. Environmental Toxicology and Chemistry 2007, 26:85-91.
22. Chu S., Metcalfe C.D. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry. Journal of Chromatography A 2007, 1163:112-118.
23. Clubbs R.L., Brooks B.W. Daphnia magna responses to a vertebrate estrogen receptor agonist and an antagonist: a multigenerational study. Ecotoxicology and Environmental Safety 2007, 67:385-398.
24. Conners D.E., Rogers E.D., Armbrust K.L., Kwon J.-W., Black M.C. Growth and development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and sertraline, throughout metamorphosis. Environmental Toxicology and Chemistry 2009, 28:2671-2676.
25. Connors K.A., Valenti T.W., Lawless K., Sackerman J., Onaivi E.S., Brooks B.W., Gould G.G. Similar effects of anxiolytics targeting putative serotonin 5-H T1A to those targeting cannabinoid CB1 receptors on zebrafish (Danio rerio) behavior in novel environments. Aquatic Toxicology 2014, http://dx.doi.org/10.1016/j.aquatox.2013.12.005.
26. Connors K.A., Du B., Fitzsimmons P.N., Hoffman A.D., Chambliss C.K., Nichols J.W., Brooks B.W. Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions. Environmental Toxicology and Chemistry 2013, 32:1810-1818.
27. Connors K.A., Du B., Fitzsimmons P.N., Hoffman A.D., Chambliss C.K., Nichols J.W., Brooks B.W. Enantiomer-specific biotransformation of select pharmaceuticals in rainbow trout (Oncorhynchus mykiss). Chirality 2013, 25:763-767.
28. Du B., Perez-Hurtado P., Brooks B.W., Chambliss C.K. Evaluation of an isotope dilution liquid chromatography tandem mass spectrometry method for pharmaceuticals in fish. Journal of Chromatography A 2012, 1253:177-183.
29. Du B., Price A.E., Scott W.C., Kristofco L.A., Ramirez A.J., Chambliss C.K., Yelderman J.C., Brooks B.W. Comparison of contaminants of emerging concern removal, discharge and water quality hazards among centralized and on-site wastewater treatment systems receiving common wastewater influent. Science of the Total Environment 2014, 466-467:976-984.
30. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environmental Science and Technology 2010, 44:2661-2666.
31. Fitzsimmons P.N., Fernadez J.D., Hoffman A.D., Butterworth B.C., Nichols J.W. Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology 2001, 55:23-34.
32. Fong P.P., Huminski P.T., D'Urso L.M. Induction and potentiation of parturition in fingernail clams (Sphaerium striatinum) by selective serotonin re-uptake inhibitors (SSRIs). Journal of Experimental Zoology 1998, 280:260-264.
33. Fong P.P., Ford A.T. The biological effects of antidepressants on the molluscs and crustaceans: a review. Aquatic Toxicology 2014, http://dx.doi.org/10.1016/j.aquatox.2013.12.003.
34. Foran C.M., Weston J.J., Slattery M., Brooks B.W., Huggett D.B. Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine exposure. Archives of Environmental Contamination and Toxicology 2004, 46:511-517.
35. Franco A., Ferranti A., Davidsen C., Trapp S. An unexpected challenge: ionizable compounds in the REACH chemical space. International Journal of Life Cycle Assessment 2010, 15:321-325.
36. Franzellitti S., Burattia S., Capolupoa M., Du B., Haddad S.P., Chambliss C.K., Brooks B.W., Fabbri E. An exploratory investigation of various modes of action and potential adverse outcomes of fluoxetine in marine mussels. Aquatic Toxicology 2014, http://dx.doi.org/10.1016/j.aquatox.2013.11.016.
37. Frazer A. Pharmacology of antidepressants. Journal of Clinical Psychopharmacology 1997, 17:2S-18S.
38. Gaworecki K.M., Klaine S.J. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquatic Toxicology 2008, 88:207-213.
39. 3H] Citalopram binding to serotonin transporter sites in minnow brains. Basic and Clinical Pharmacology and Toxicology 2007, 101:203-210.
40. Guler Y., Ford A.T. Anti-depressants make amphipods see the light. Aquatic Toxicology 2010, 99:397-404.
41. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessment. Environmental Science and Technology 2008, 42:5807-5813.
42. Hazelton P.D., Du B., Haddad S.P., Fritts A.K., Chambliss C.K., Brooks B.W., Bringolf R.B. Chronic fluoxetine exposure alters movement and burrowing in adult freshwater mussels. Aquatic Toxicology 2014, http://dx.doi.org/10.1016/j.aquatox.2013.12.019.
43. Henry T.B., Kwon J.W., Armbrust K.L., Black M.C. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environmental Toxicology and Chemistry 2004, 23:2229-2233.
44. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Human and Ecological Risk Assessment 2003, 9:1789-1799.
45. Jacobsen N.W., Brooks B.W., Halling-Sørensen B. Suggesting a testing strategy for possible endocrine effects of drug metabolites. Regulatory Toxicology and Pharmacology 2012, 62:441-448.
46. Kwon J.W., Armbrust K.L. Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions. Environmental Toxicology and Chemistry 2004, 23:1394-1399.
47. Larsson D.G.J., de Pedro C., Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. Journal of Hazardous Materials 2007, 148:751-755.
48. Lynn S.E., Egar J.M., Walker B.G., Sperry T.S., Ramenofsky M. Fish on Prozac: a simple, noninvasive physiology laboratory investigating the mechanisms of aggressive behavior in Betta splendens. Advances in Physiology Education 2007, 31:358-363.
49. Margiotta-Casaluci L., Hannah R.E., Sumpter J.P. Mode of action of human pharmaceuticals in fish: the effects of the 5-alpha-reductase inhibitor, dutasteride, on reproduction as a case study. Aquatic Toxicology 2013, 128-129:113-123.
50. McRobb F.M., Sahagún V., Kufareva I., Abagyan R. In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species. Environmental Science and Technology 2014, 10.1021/es404568a.
51. Mennigen J.A., Sassine J., Trudeau V.L., Moon T.W. Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. Aquatic Toxicology 2010, 100:128-137.
52. Mennigen J.A., Lado W.E., Zamora J.M., Duarte-Guterman P., Langlois V.S., Metcalfe C.D., Chang J.P., Moon T.W., Trudeau V.L. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish Carassius auratus. Aquatic Toxicology 2010, 100:354-364.
53. Mennigen J.A., Stroud P., Zamora J.M., Moon T.W., Trudeau V.L. Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac. Journal of Toxicology and Environmental Health, Part B: Critical Reviews 2011, 14:387-412.
54. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A.B.A. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environmental Pollution 2012, 165:250-258.
55. Monteiro S.C., Boxall A.B.A. Factors affecting the degradation of pharmaceuticals in agricultural soils. Environmental Toxicology and Chemistry 2009, 28:2546-2554.
56. Nakamura Y., Yamamoto H., Sekizawa J., Kondo T., Hirai N., Tatarako N. The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 2008, 70:865-873.
57. Nentwig G. Effects of pharmaceuticals on aquatic invertebrates Part II: The antidepressant drug fluoxetine. Archives of Environmental Contamination and Toxicology 2007, 52:163-170.
58. Oakes K.D., Coors A., Escher B.I., Fenner K., Garric J., Gust M., Knacker T., Küster A., Kussatz C., Metcalfe C.D., Monteiro S., Moon T.W., Mennigen J.A., Parrott J., Péry A.R.R., Ramil M., Roennefahrt I., Tarazona J.V., Sánchez-Argüello P., Ternes T.A., Trudeau V.L., Boucard T., Van Der Kraak G.J., Servos M.R. Environmental risk assessment for the serotonin re- uptake inhibitor fluoxetine: case study using the European risk assessment framework. Integrated Environmental Assessment and Management 2010, 6(Suppl 1):524-539.
59. Painter M.M., Buerkley M.A., Julius M.L., Vajda A.M., Norris D.O., Barber L.B., Furlong E.T., Schultz M.M., Schoenfuss H.L. Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas). Environmental Toxicology and Chemistry 2009, 28:2677-2684.
60. Paterson G., Metcalfe C.D. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 2008, 74:125-130.
61. Perkins E.J., Ankley G.T., Crofton K.M., Garcia-Reyero N., LaLone C.A., Johnson M.S., Tietge J.E., Villeneuve D.L. Current perspectives on the use of alternative species in human health and ecological hazard assessments. Environmental Health Perspectives 2013, 121:1002-1010.
62. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish tissue using liquid chromatography-tandem mass spectrometry. Analytical Chemistry 2007, 79:3155-3163.
63. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products (PPCPs) in fish: results of a national pilot study in the U.S. Environmental Toxicology and Chemistry 2009, 28:2587-2597.
64. Rand-Weaver M., Margiotta-Casaluci L., Patel A., Panter G.H., Owen S.F., Sumpter J.P. The read-across hypothesis and environmental risk assessment of pharmaceuticals. Environmental Science and Technology 2013, 47:11384-11395.
65. Roos V., Gunnarsson L., Fick J., Larsson D.G.J., Ruden C. Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Science of the Total Environment 2012, 421-422:102-110.
66. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Analytical Chemistry 2008, 80:1756-1762.
67. Schulz M., Iwersen-Bergmann S., Andresen H., Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Critical Care 2012, 16:R136.
68. Seiler J.P. Pharmacodynamic activity of drugs and ecotoxicology-can the two be connected?. Toxicology Letters 2002, 131:105-115.
69. Smith E.M., Chu S.G., Paterson G., Metcalfe C.D., Wilson J.Y. Cross-species comparison of fluoxetine metabolism with fish liver microsomes. Chemosphere 2010, 79:26-32.
70. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
71. Stanley J.K., Brooks B.W. Perspectives on ecological risk assessment of chiral compounds. Integrated Environmental Assessment and Management 2009, 5:364-373.
72. Subedi B., Du B., Chambliss C.K., Koschorrek J., Rudel H., Quack M., Brooks B.W., Usenko S. Occurrence of pharmaceuticals and personal care products in German fish tissue: a national study. Environmental Science and Technology 2012, 46:9047-9056.
73. Valenti T.W., Perez Hurtado P., Chambliss C.K., Brooks B.W. Aquatic toxicity of sertraline to Pimephales promelas at environmentally relevant surface water pH. Environmental Toxicology and Chemistry 2009, 28:2685-2694.
74. Valenti T.W., Taylor J.T., Back J.A., King R.S., Brooks B.W. Influence of drought and total phosphorus on diel pH in wadeable streams: implications for ecological risk assessment of ionizable contaminants. Integrated Environmental Assessment and Management 2011, 7:636-647.
75. Valenti T.W., Gould G.G., Berninger J.P., Connors K.A., Keele N.B., Prosser K.N., Brooks B.W. Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows. Environmental Science and Technology 2012, 46:2427-2435.
76. Voutchkova A.M., Kostal J., Steinfeld J.B., Emerson J.W., Brooks B.W., Anastas P., Zimmerman J.B. Towards rational molecular design: derivation of property guidelines for reduced acute aquatic toxicity. Green Chemistry 2011, 13:2373-2379.
77. Voutchkova-Kostal A.M., Kostal J., Connors K.A., Brooks B.W., Anastas P., Zimmerman J.B. Towards rational molecular design for reduced chronic aquatic toxicity. Green Chemistry 2012, 14:1001-1008.
78. Weinberger J., Klaper R. Environmental concentrations of the selective serotonin reuptake inhibitor fluoxetine impact specific behaviors involved in reproduction, feeding and predator avoidance in the fish Pimephales promelas (fathead minnow). Aquatic Toxicology 2014, http://dx.doi.org/10.1016/j.aquatox.2013.10.012.
79. Zhang X., Oakes K.D., Cui S.F., Bragg L., Servos M.R., Pawliszyn J. Tissue-specific in vivo bioconcentration of pharmaceuticals in rainbow trout (Oncorhynchus mykiss) using space-resolved solid-phase microextraction. Environmental Science and Technology 2010, 44:3417-3422.
80. Zhou S.N., Oakes K.D., Servos M.R., Pawliszyn J. Application of solid-phase microextraction for in vivo laboratory and field sampling of pharmaceuticals in fish. Environmental Science and Technology 2008, 42:6073-6079.